Perfil
Jens Bjørheim currently works at Zelluna ASA, as Chief Medical Officer.
Dr. Bjørheim also formerly worked at Pronova BioPharma ASA, as Medical Director from 2006 to 2008, AstraZeneca A, as Senior Medical Director-Oncology from 2013 to 2016, and Ultimovacs ASA, as Chief Medical Officer.
Dr. Bjørheim received his doctorate degree in 1999 from the University of Oslo and doctorate degree in 2003 from the University of Oslo.
Cargos activos de Jens Bjørheim
| Empresas | Cargo | Inicio |
|---|
Antiguos cargos conocidos de Jens Bjørheim.
| Empresas | Cargo | Fin |
|---|---|---|
AstraZeneca A/S (Denmark)
AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines | Corporate Officer/Principal | 01/01/2016 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals | Director Técnico/Científico/I+D | 01/01/2008 |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Director Técnico/Científico/I+D | - |
Formación de Jens Bjørheim.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca A/S (Denmark)
AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines | Health Technology |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
- Bolsa de valores
- Insiders
- Jens Bjørheim
















